BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ali A, Palakkott A, Ashraf A, Al Zamel I, Baby B, Vijayan R, Ayoub MA. Positive Modulation of Angiotensin II Type 1 Receptor-Mediated Signaling by LVV-Hemorphin-7. Front Pharmacol 2019;10:1258. [PMID: 31708782 DOI: 10.3389/fphar.2019.01258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Dale NC, White CW, Johnstone EK, Pfleger KD. Bioluminescence Resonance Energy Transfer ( BRET ) Technologies to Study GPCRs. GPCRs as Therapeutic Targets 2022. [DOI: 10.1002/9781119564782.ch23] [Reference Citation Analysis]
2 Khan FB, Anwar I, Redwan EM, Palakkott A, Ashraf A, Kizhakkayil J, Iratni R, Maqsood S, Akli Ayoub M. Camel and bovine milk lactoferrins activate insulin receptor and its related AKT and ERK1/2 pathways. J Dairy Sci 2021:S0022-0302(21)01069-9. [PMID: 34955280 DOI: 10.3168/jds.2021-20934] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
3 Olson KM, Traynor JR, Alt A. Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators. Front Chem 2021;9:671483. [PMID: 34692635 DOI: 10.3389/fchem.2021.671483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
4 Al Zamel I, Palakkott A, Ayoub MA. Synergistic activation of thrombin and angiotensin II receptors revealed by bioluminescence resonance energy transfer. FEBS Lett 2021;595:2628-37. [PMID: 34455594 DOI: 10.1002/1873-3468.14187] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mielczarek P, Hartman K, Drabik A, Hung HY, Huang EY, Gibula-Tarlowska E, Kotlinska JH, Silberring J. Hemorphins-From Discovery to Functions and Pharmacology. Molecules 2021;26:3879. [PMID: 34201982 DOI: 10.3390/molecules26133879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ayoub MA, Vijayan R. Hemorphins Targeting G Protein-Coupled Receptors. Pharmaceuticals (Basel) 2021;14:225. [PMID: 33799973 DOI: 10.3390/ph14030225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ali A, Johnstone EKM, Baby B, See HB, Song A, Rosengren KJ, Pfleger KDG, Ayoub MA, Vijayan R. Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor. Int J Mol Sci 2020;22:E209. [PMID: 33379211 DOI: 10.3390/ijms22010209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ashraf A, Mudgil P, Palakkott A, Iratni R, Gan CY, Maqsood S, Ayoub MA. Molecular basis of the anti-diabetic properties of camel milk through profiling of its bioactive peptides on dipeptidyl peptidase IV (DPP-IV) and insulin receptor activity. J Dairy Sci 2021;104:61-77. [PMID: 33162074 DOI: 10.3168/jds.2020-18627] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 12.0] [Reference Citation Analysis]
9 Ali A, Alzeyoudi SAR, Almutawa SA, Alnajjar AN, Vijayan R. Molecular basis of the therapeutic properties of hemorphins. Pharmacol Res 2020;158:104855. [PMID: 32438036 DOI: 10.1016/j.phrs.2020.104855] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
10 Ali A, Alzeyoudi SAR, Almutawa SA, Alnajjar AN, Al Dhaheri Y, Vijayan R. Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study. Biomolecules 2020;10:E486. [PMID: 32210030 DOI: 10.3390/biom10030486] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]